CureVac NV Shares Owned By Institutions vs. Price To Sales
| CVAC Stock | USD 3.27 0.06 1.87% |
For CureVac NV profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CureVac NV to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CureVac NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CureVac NV's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CureVac NV over time as well as its relative position and ranking within its peers.
CureVac |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.49 | Revenue Per Share 0.294 | Quarterly Revenue Growth 0.905 | Return On Assets (0.25) | Return On Equity (0.54) |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CureVac NV Price To Sales vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CureVac NV's current stock value. Our valuation model uses many indicators to compare CureVac NV value to that of its competitors to determine the firm's financial worth. CureVac NV is number one stock in shares owned by institutions category among its peers. It also is number one stock in price to sales category among its peers fabricating about 0.59 of Price To Sales per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Price To Sales for CureVac NV is roughly 1.70 . At present, CureVac NV's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CureVac NV's earnings, one of the primary drivers of an investment's value.CureVac Price To Sales vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
CureVac NV |
| = | 18.87 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
CureVac NV |
| = | 11.12 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CureVac Price To Sales Comparison
CureVac NV is currently under evaluation in price to sales category among its peers.
CureVac NV Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CureVac NV, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CureVac NV will eventually generate negative long term returns. The profitability progress is the general direction of CureVac NV's change in net profit over the period of time. It can combine multiple indicators of CureVac NV, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.1 B | 1.4 B | |
| Net Interest Income | 5.5 M | 5.7 M | |
| Interest Income | 12.9 M | 13.6 M | |
| Operating Income | -274.2 M | -287.9 M | |
| Net Loss | -302.3 M | -317.4 M | |
| Income Before Tax | -260 M | -273 M | |
| Total Other Income Expense Net | 14.2 M | 14.9 M | |
| Net Loss | -370.5 M | -352 M | |
| Net Loss | -260.2 M | -273.2 M | |
| Income Tax Expense | 198 K | 207.9 K | |
| Change To Netincome | -325 M | -308.7 M | |
| Net Loss | (1.18) | (1.24) | |
| Income Quality | 1.03 | 1.08 | |
| Net Income Per E B T | 1.00 | 0.80 |
CureVac Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CureVac NV. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CureVac NV position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CureVac NV's important profitability drivers and their relationship over time.
Use CureVac NV in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CureVac NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will appreciate offsetting losses from the drop in the long position's value.CureVac NV Pair Trading
CureVac NV Pair Trading Analysis
The ability to find closely correlated positions to CureVac NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CureVac NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CureVac NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CureVac NV to buy it.
The correlation of CureVac NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CureVac NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CureVac NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CureVac NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CureVac NV position
In addition to having CureVac NV in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipbuilding Railroad Equipment Thematic Idea Now
Shipbuilding Railroad Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
To fully project CureVac NV's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CureVac NV at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CureVac NV's income statement, its balance sheet, and the statement of cash flows.